Table 3.
Score | 0 | 0.5 | 1 | 1.5 | 2 |
---|---|---|---|---|---|
Prognostic variables | |||||
% bone marrow blasts | <5% | 5%–10% | 11%–19% | 20%–30%* | |
Karyotype** | Good | Intermediate | Poor | ||
Cytopenias*** | 0–1 | 2–3 |
Notes:
This group is recognized as AML in the WHO classification;
Karyotype: Good = normal, −Y, del (5q), del (20q); Poor = complex (≥3 abnormalities) or chromosome 7 anomalies; Intermediate = other abnormalities;
Cytopenias: Hgb <10 g/dL; Neutrophils <1.8 × 109/L; Platelets <100 × 109/L.
Abbreviations: MDS, myelodysplastic syndrome; AML, acute myeloid leukemia; WHO, world health organization.